Related Experiment Video

Updated: Oct 13, 2025

Author Spotlight: Analyzing Bone Marrow Microenvironment in Murine Hematological Malignancies
06:33

Author Spotlight: Analyzing Bone Marrow Microenvironment in Murine Hematological Malignancies

Published on: November 10, 2023

1.4K

Bone marrow microenvironment of MPN cells

Alessandro Malara1, Christian A Di Buduo1, Vittorio Abbonante1

  • 1Department of Molecular Medicine, University of Pavia, Pavia, Italy.

International Review of Cell and Molecular Biology
|November 10, 2021
PubMed

Insights

This chapter explores bone marrow changes in Myeloproliferative Neoplasms (MPNs). It highlights the key role of megakaryocytes in disease progression and the fibrotic extracellular matrix in MPN bone marrow.

Area of Science:

  • Hematology
  • Oncology
  • Cell Biology

Background:

  • Myeloproliferative Neoplasms (MPNs) are a group of blood cancers characterized by the overproduction of myeloid cells.
  • The bone marrow microenvironment, or niche, plays a critical role in MPN pathogenesis and progression.
  • Alterations in cellular and extracellular components of the bone marrow niche are increasingly recognized as important factors in MPNs.

Purpose of the Study:

  • To review current knowledge on bone marrow niche alterations in MPNs.
  • To emphasize the role of megakaryocytes in MPN progression.
  • To describe the extracellular matrix components associated with fibrotic bone marrow in MPNs.

Main Methods:

  • Literature review of existing research on MPNs and bone marrow microenvironment.
  • Analysis of cellular components, focusing on megakaryocytes.
  • Examination of extracellular matrix characteristics in fibrotic bone marrow.

Main Results:

  • Megakaryocytes are central players in the progression of Myeloproliferative Neoplasms.
  • Specific alterations in bone marrow cellular components are observed in MPNs.
  • The extracellular matrix in fibrotic bone marrow of MPN patients exhibits distinct features.

Conclusions:

  • Understanding bone marrow niche alterations is crucial for comprehending MPN pathogenesis.
  • Megakaryocyte dynamics are a key therapeutic target in MPNs.
  • Characterization of the fibrotic bone marrow environment may lead to novel diagnostic or therapeutic strategies.
Keywords:
Bone marrowExtracellular matrixMegakaryocytesMyeloproliferative neoplasms

More Related Videos

Bioengineering of Humanized Bone Marrow Microenvironments in Mouse and Their Visualization by Live Imaging10:03

Bioengineering of Humanized Bone Marrow Microenvironments in Mouse and Their Visualization by Live Imaging

Published on: August 1, 2017

11.9K
Ex vivo Mimicry of Normal and Abnormal Human Hematopoiesis11:50

Ex vivo Mimicry of Normal and Abnormal Human Hematopoiesis

Published on: April 10, 2012

15.6K

Related Concept Videos

Differentiation of Common Myeloid Progenitor Cells01:15

Differentiation of Common Myeloid Progenitor Cells

Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
3.4K
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.0K
Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.4K
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
561
Production of Formed Elements01:34

Production of Formed Elements

Hemangioblasts are multipotent stem cells originating from the mesoderm. They give rise to hematopoietic stem cells (HSCs), which undergo hematopoiesis to produce all the formed elements of blood. This process is regulated by a complex network of hematopoietic growth factors, including transcription factors, growth factors, and cytokines. These factors stimulate the HSCs to divide and differentiate, though some HSCs remain undifferentiated to maintain a self-renewing pool.
Most HSCs commit to...
2.4K